{
    "title": "Novo eyes other health benefits from weight-loss drug Wegovy after major trial",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12393227/Novo-eyes-health-benefits-weight-loss-drug-Wegovy-major-trial.html",
    "date": "2023-08-10",
    "keywords": [
        "risk",
        "heart",
        "trial",
        "lange",
        "health",
        "drug",
        "disease",
        "skydsgaard",
        "weight",
        "development",
        "benefit",
        "wegovy",
        "kidney",
        "failure",
        "hospitalisation",
        "semaglutide",
        "jacob",
        "gronholtpedersen",
        "copenhagen",
        "executive",
        "drugmaker",
        "week",
        "select",
        "injection",
        "company",
        "approval",
        "exercise",
        "analysis",
        "number",
        "vice",
        "president",
        "martin",
        "holst",
        "boost",
        "image",
        "data",
        "europe",
        "cost",
        "wider",
        "range",
        "month",
        "thursday",
        "outlook",
        "back",
        "obesity",
        "ozempic",
        "ingredient",
        "allcause",
        "mortality",
        "look",
        "blood",
        "pressure",
        "cholesterol",
        "inflammation",
        "picture",
        "association",
        "conference",
        "philadelphia",
        "novo",
        "treatment",
        "placebo",
        "dialogue",
        "claim",
        "delay",
        "reporting",
        "editing",
        "josephine",
        "mason",
        "donovan"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}